Charis Eng, MD, PhD, Genomic Medicine Institute – Cleveland Clinic, explains SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia at AACR 2018.
SEC23B is Altered For Rare Blood Disorder Type II Congenital dyserythropoietic anemia
